|
1
|
Shan X, Fu YS, Aziz F, Wang XQ, Yan Q and
Liu JW: Ginsenoside Rg3 inhibits melanoma cell proliferation
through down-regulation of histone deacetylase 3 (HDAC3) and
increase of p53 acetylation. PLoS One. 9:e1154012014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Joo EJ, Chun J, Ha YW, Ko HJ, Xu MY and
Kim YS: Novel roles of ginsenoside Rg3 in apoptosis through
downregulation of epidermal growth factor receptor. Chem Biol
Interact. 233:25–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shan X, Tian LL, Zhang YM, Wang XQ, Yan Q
and Liu JW: Ginsenoside Rg3 suppresses FUT4 expression through
inhibiting NF-κB/p65 signaling pathway to promote melanoma cell
death. Int J Oncol. 47:701–709. 2015.PubMed/NCBI
|
|
4
|
Zeng D, Wang J, Kong P, Chang C and Li J
and Li J: Ginsenoside Rg3 inhibits HIF-1α and VEGF expression in
patient with acute leukemia via inhibiting the activation of
PI3K/Akt and ERK1/2 pathways. Int J Clin Exp Pathol. 7:2172–2178.
2014.PubMed/NCBI
|
|
5
|
Luo Y, Zhang P, Zeng HQ, Lou SF and Wang
DX: Ginsenoside Rg3 induces apoptosis in human multiple myeloma
cells via the activation of Bcl-2-associated X protein. Mol Med
Rep. 12:3557–3562. 2015.PubMed/NCBI
|
|
6
|
Ge X, Zhen F, Yang B, Yang X, Cai J, Zhang
C, Zhang S, Cao Y, Ma J, Cheng H and Sun X: Ginsenoside Rg3
enhances radiosensitization of hypoxic oesophageal cancer cell
lines through vascular endothelial growth factor and hypoxia
inducible factor 1α. J Int Med Res. 42:628–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim JH, Cho SY, Lee JH, Jeong SM, Yoon IS,
Lee BH, Lee JH, Pyo MK, Lee SM, Chung JM, et al: Neuroprotective
effects of ginsenoside Rg3 against homocysteine-induced
excitotoxicity in rat hippocampus. Brain Res. 1136:190–199. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoon SJ, Park JY, Choi S, Lee JB, Jung H,
Kim TD, Yoon SR, Choi I, Shim S and Park YJ: Ginsenoside Rg3
regulates S-nitrosylation of the NLRP3 inflammasome via suppression
of iNOS. Biochem Biophys Res Commun. 463:1184–1189. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Paska AV and Hudler P: Aberrant
methylation patterns in cancer: A clinical view. Biochem Med
(Zagreb). 25:161–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poke FS, Qadi A and Holloway AF: Reversing
aberrant methylation patterns in cancer. Curr Med Chem.
17:1246–1254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Price RJ, Lillycrop KA and Burdge GC:
Folic acid supplementation in vitro induces cell type-specific
changes in BRCA1 and BRCA 2 mRNA expression, but does not alter DNA
methylation of their promoters or DNA repair. Nutr Res. 35:532–544.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gadgil MS, Joshi KS, Naik SS, Pandit AN,
Otiv SR and Patwardhan BK: Association of homocysteine with global
DNA methylation in vegetarian Indian pregnant women and neonatal
birth anthropometrics. J Matern Fetal Neonatal Med. 27:1749–1753.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sie KK, Li J, Ly A, Sohn KJ, Croxford R
and Kim YI: Effect of maternal and postweaning folic acid
supplementation on global and gene-specific DNA methylation in the
liver of the rat offspring. Mol Nutr Food Res. 57:677–685. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sceusi EL, Loose DS and Wray CJ: Clinical
implications of DNA methylation in hepatocellular carcinoma. HPB
(Oxford). 13:369–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Komatsu Y, Waku T, Iwasaki N, Ono W,
Yamaguchi C and Yanagisawa J: Global analysis of DNA methylation in
early-stage liver fibrosis. BMC Med Genomics. 5:52012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nishida N and Kudo M: Alteration of
epigenetic profile in human hepatocellular carcinoma and its
clinical implications. Liver Cancer. 3:417–427. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu R, Ru Q, Chen L, Ma B and Li C:
Stereospecificity of ginsenoside Rg3 in the promotion of cellular
immunity in hepatoma H22-bearing mice. J Food Sci. 79:H1430–H1435.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K,
Kim TJ, Ham J, Jang HJ, Kang KS and Ko H: Stereospecific effects of
ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal
transition and suppresses lung cancer migration, invasion and
anoikis resistance. Toxicology. 322:23–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park EH, Kim YJ, Yamabe N, Park SH, Kim
HK, Jang HJ, Kim JH, Cheon GJ, Ham J and Kang KS: Stereospecific
anticancer effects of ginsenoside Rg3 epimers isolated from
heat-processed American ginseng on human gastric cancer cell. J
Ginseng Res. 38:22–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheong JH, Kim H, Hong MJ, Yang MH, Kim
JW, Yoo H, Yang H, Park JH, Sung SH, Kim HP and Kim J:
Stereoisomer-specific anticancer activities of ginsenoside Rg3 and
Rh2 in HepG2 cells: Disparity in cytotoxicity and
autophagy-inducing effects due to 20(S)-epimers. Biol Pharm Bull.
38:102–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fragou D, Zanos P, Kouidou S, Njau S,
Kitchen I, Bailey A and Kovatsi L: Effect of chronic heroin and
cocaine administration on global DNA methylation in brain and
liver. Toxicol Lett. 218:260–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou B, Wang J and Yan Z: Ginsenoside Rg3
attenuates hepatoma VEGF overexpression after hepatic artery
embolization in an orthotopic transplantation hepatocellular
carcinoma rat model. Onco Targets Ther. 7:1945–1954. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan HD, Quan HY, Zhang Y, Kim SH and
Chung SH: 20(S)-Ginsenoside Rg3-induced apoptosis in HT-29 colon
cancer cells is associated with AMPK signaling pathway. Mol Med
Rep. 3:825–831. 2010.PubMed/NCBI
|
|
25
|
Lü JM, Yao Q and Chen C: Ginseng
compounds: An update on their molecular mechanisms and medical
applications. Curr Vasc Pharmacol. 7:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang F, Li M, Wu X, Hu Y, Cao Y, Wang X,
Xiang S, Li H, Jiang L, Tan Z, et al: 20(S)-ginsenoside Rg3
promotes senescence and apoptosis in gallbladder cancer cells via
the p53 pathway. Drug Des Devel Ther. 9:3969–3987. 2015.PubMed/NCBI
|
|
27
|
Oh BK, Kim H, Park HJ, Shim YH, Choi J,
Park C and Park YN: DNA methyltransferase expression and DNA
methylation in human hepatocellular carcinoma and their
clinicopathological correlation. Int J Mol Med. 20:65–73.
2007.PubMed/NCBI
|
